http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2576815-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e19c12ac350fc1c0c02bcf301685e6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea00e71425c7a22cd425b05530e2964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_752fb87a91c2200d55fb867dbd108a5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_307974145c4417534d5440c9a55b1fcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36741b9da50f916e2f624973be546f35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efd17303029374fc947d9bb3735c0592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f2be0f710ac50fec0accd42ed3b1db |
| publicationDate | 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2576815-A1 |
| titleOfInvention | Method and kit for the prognosis of colorectal cancer |
| abstract | The present invention relates to method and kit for the prognosis of colorectal cancer. Especially a method comprising: a) obtaining the peripheral blood sample and extracting total RNA from the blood sample, b) contacting the total RNA with at least one reagent that is specific for at least one NK cell gene and no more than 25 specific reagents for 25 NK cell genes, c) determining the expression level of the at least one NK cell gene and of the most 25 NK cell genes to obtain an expression profile for the patient, d) performing analysis of the expression profile of the patient with expression profiles of NK cell genes from patients previously clinically classified as a good prognosis and expression profiles of NK cell genes from patients previously classified as a poor prognosis, wherein - if the expression profile for the patient is clustered with the expression profiles from patients previously clinically classified as a poor prognosis, then the patient is determined to have a poor prognosis, and - if the expression profile for the patient is clustered with the expression profiles from patients previously clinically classified as a good prognosis, then the patient is determined to have a good prognosis. |
| priorityDate | 2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 341.